New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient’s diagnosis, leads to ...

Shaiken, T. E., Grimm, S. L., Siam, M., Williams, A., Rezaeian, A. H., Kraushaar, D., Ricco, E., Robertson, M. J., Coarfa, C., Jain, A., Malovannaya, A., Stossi, F ...

New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses the latest advancements in HR+/HER2– breast cancer research, as well as the ...

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in ...

Cambridge-based Tagomics Ltd., a biomarker discovery and diagnostics company, has entered into a strategic co-marketing ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts ...

The agreement involves the integration of Tagomics' Interlace epigenetic profiling platform with Agilent's SureSelect library preparation and target enrichment products.